LAS100977 will be developed using GENUAIR ®, a novel, state-of-the-art, multi-dose dry powder inhaler (MDPI). GENUAIR ® was designed with an intuitive click and color feedback system which, through a ...
Company to develop combination treatment based on inhaled long-acting beta2 agonist. Forest Laboratories is paying Almirall $75 million up front as part of a U.S. development, marketing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results